Although there is insufficient evidence to show that there is an epidemiological predilection between different CPVT-associated mutations, the lack of reports on CALM1, CALM2, CALM3, and TRDN mutations highlights their rarity and the need to examine the global trends of genetic mutations in CPVT. This evidence concerns the gene CALM2 and catecholaminergic polymorphic ventricular tachycardia.